Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$852K Buy
7,085
+2,293
+48% +$265K 0.23% 75
2025
Q4
$504K Buy
+4,792
New +$450K 0.15% 97
2024
Q3
Sell
-1,957
Closed -$244K 134
2024
Q2
$244K Buy
1,957
+400
+26% +$51.5K 0.13% 112
2024
Q1
$205K Buy
+1,557
New +$192K 0.12% 116
2023
Q3
Sell
-1,945
Closed -$224K 107
2023
Q2
$224K Hold
1,945
0.15% 101
2023
Q1
$207K Sell
1,945
-289
-13% -$31.2K 0.17% 104
2022
Q4
$248K Buy
2,234
+1
+0% +$102 0.15% 103
2022
Q3
$192K Buy
+2,233
New +$199K 0.13% 109
2021
Q2
Sell
-1,003
Closed -$73K 255
2021
Q1
$73K Hold
1,003
0.04% 172
2020
Q4
$79K Buy
+1,003
New +$76.7K 0.06% 165

Other funds holding MRK

COWA LLC's MRK Position: Q1 2026 in Review

COWA LLC increased its Merck (MRK) stake by 48% in Q1 2026, buying an estimated $265K and bringing the position to 7,085 shares worth $852K. The position accounts for 0.23% of the portfolio, ranked #75.

COWA LLC first reported a position in MRK in Q4 2020 and has held it in 10 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • COWA LLC held 7,085 shares of Merck worth $852K as of Q1 2026.
  • COWA LLC bought 2,293 Merck shares in Q1 2026, an estimated $265K.
  • Merck made up 0.23% of COWA LLC's portfolio in Q1 2026, its #75 holding.
  • COWA LLC first reported a position in Merck in Q4 2020 and has held it in 10 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on COWA LLC's 13F filing for Q1 2026, filed 14 May 2026.